PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists lead study on ‘spray on, wash off’ bandages for painful EB condition

Research into new bandaging aims to ease the agony experienced by those living with 'butterfly skin'

2024-11-18
(Press-News.org)

Research into new bandaging aims to ease the agony experienced by those living with genetic skin condition Epidermolysis Bullosa (EB), commonly referred to as 'butterfly skin'.

Scientists at Maynooth University in Ireland are leading research into whether ‘spray on, wash off’ bandages will be a viable alternative to those currently used, which can cause severe pain when applied and removed.

EB, which affects over 500,000 children and adults worldwide including 5,000 in the UK and 300 in Ireland, is caused by the absence of proteins between the skin layers, meaning the skin becomes ultra fragile and blisters at the mildest touch.

In severe cases, such as Recessive Dystrophic EB, bandage changes to protect wounds and prevent blister infection are required every day and can last three to four hours at a time.

The two-year study by Maynooth University received co-funding of almost €113,000 from Debra Ireland, an Irish charity supporting those living with EB, and the Irish Research Council (IRC).

Its key aim will be to enable scientists to develop a prototype, with the hope of allowing non-abrasive bandages to be sprayed onto the skin. By placing them under cold water, it is hoped that they will then melt away and be removed painlessly.

“Bandage changes are a particularly excruciating element of this condition and research of this nature has the potential to make a real difference for people living with EB,” said Jimmy Fearon, CEO of Debra Ireland.

“We hope its outcome might contribute to improved quality of life for those living with EB in Ireland, and beyond.”

“The aim, ultimately, is not to cause further damage to the skin,” said Dr Robert Elmes, Associate Professor at the Department of Chemistry at Maynooth University and a Funded Investigator at SSPC, the Science Foundation Ireland Research Centre for Pharmaceuticals.

“We use supramolecular chemistry as the basis to the research, studying how molecules interact with each other and how we can predict how they will separate from each other as they cool.

“This is an excellent example of a fundamental area of chemical science having a potentially life-changing impact on the everyday lives of people with EB."

Pricing for the bandages is not expected to be out of reach of those living with EB as the materials used are widely available and completely harmless to the skin.

The work will be carried out by Dr Hilal Kirpik, of Maynooth University’s Department of Chemistry, who is passionate about the real world impact of chemical research. “By the end of the project, we hope to have a prototype that people can take home and administer themselves without the need for painful bandage removal,” said Dr Elmes, research project supervisor.

EB was recently highlighted by Patient Ambassador for Debra, Emma Fogarty, who suffers from this painful condition, and Irish actor Colin Farrell who both participated in the Dublin Marathon in October to highlight the condition. 

Ends



END


ELSE PRESS RELEASES FROM THIS DATE:

A new discovery about pain signalling may contribute to better treatment of chronic pain

A new discovery about pain signalling may contribute to better treatment of chronic pain
2024-11-18
When pain signals are passed along the nervous system, proteins called calcium channels play a key role. Researchers at Linköping University, Sweden, have now pinpointed the exact location of a specific calcium channel fine-tuning the strength of pain signals. This knowledge can be used to develop drugs for chronic pain that are more effective and have fewer side effects. Pain sensations and other information are mainly conducted through our nervous system as electrical signals. Yet at decisive moments, this information is converted to biochemical signals, in the form of specific molecules. To develop future drugs ...

Migrating birds have stowaway passengers: invasive ticks could spread novel diseases around the world

2024-11-18
Ticks travel light, but they carry pathogens with them. When they parasitize migrating birds, these journeys can take them thousands of miles away from their usual geographic range. Historically, they haven’t been able to establish themselves, due to unsuitable climate conditions at the other end of their long journeys. But now, thanks to the climate crisis, it’s getting easier for ticks to survive and spread, potentially bringing novel tick-borne pathogens with them. “If conditions become more hospitable for tropical tick species to establish themselves in areas where they would previously have been unsuccessful, then there is a chance they could bring new diseases ...

Diabetes drug shows promise in protecting kidneys

Diabetes drug shows promise in protecting kidneys
2024-11-18
Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An Osaka Metropolitan University-led research group has investigated how such drugs maintain kidney health. Known as SGLT2 (sodium-glucose cotransporter-2) inhibitors, the drugs are used to treat type 2 diabetes along with an exercise and diet regimen. The group led by Graduate School of Medicine Associate Professor Katsuhito Mori focused on the SGLT2 inhibitor canagliflozin and its effects on the kidney. Using BOLD ...

Updated model reduces liver transplant disparities for women

2024-11-18
SAN DIEGO, California (Nov. 18, 2024) — Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the waitlist for a liver transplant, more likely to receive a transplant, and less likely to drop off the waitlist — closing the gap between men and women candidates, according to a study scheduled for presentation today at The Liver Meeting held by the American Association for the Study of Liver Diseases. In July 2023, the federal Organ Procurement and Transplant Network (OPTN) updated its Model for End-Stage Liver Disease to a new version, known as MELD 3.0, to better account for differences between ...

Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller

2024-11-18
People who take an anticoagulant medicine double their risk of an internal bleed if they take a type of painkiller called a non-steroidal anti-inflammatory drug (NSAID) such as ibuprofen, diclofenac or naproxen, according to research published in the European Heart Journal [1] today (Monday).   Anticoagulants are usually prescribed to people who develop a blood clot in the legs or lungs, known as a venous thromboembolism, which affects about one in 12 people. NSAIDs are a popular type of painkiller used to manage issues like headaches, period pain, back pain and arthritis.   The new study is the largest of its kind and shows that ...

‘Teen-friendly’ mindfulness therapy aims to help combat depression among teenagers

2024-11-18
Researchers have developed a mindfulness therapy tailored specifically to appeal to teenagers to help them cope with increasing levels of depression and mental health problems. The approach teaches participants to tune into and manage negative thought patterns that can trigger or maintain depression, and allow them instead to focus on the present moment. Developed by teams at the University of Cambridge and King’s College London, the ATTEND programme – Adolescents and carers using mindfulness Therapy To END depression – also includes sessions for parents and guardians, ensuring a family-centred approach ...

Innovative risk score accurately calculates which kidney transplant candidates are also at risk for heart attack or stroke, new study finds

Innovative risk score accurately calculates which kidney transplant candidates are also at risk for heart attack or stroke, new study finds
2024-11-17
Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake City say they can accurately predict whether patients being assessed for kidney transplant will likely have a future major cardiac event, like a heart attack or stroke, according to a new study. Intermountain Health clinicians regularly review patient data through their electronic health system to determine who may have heart disease without knowing it. Now, in a major new study, Intermountain heart researchers found that using their Intermountain ...

Kidney outcomes in transthyretin amyloid cardiomyopathy

2024-11-17
About The Study: In this retrospective cohort study, decline in kidney function was frequent in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) and was consistently associated with an increased risk of mortality, even after adjusting for established markers of worsening ATTR-CM. eGFR decline represents an independent marker of ATTR-CM disease progression that could guide treatment optimization in clinical practice.  Corresponding Author: To contact the corresponding author, Marianna Fontana, MD, PhD, email m.fontana@ucl.ac.uk. To access the embargoed study: ...

Partial cardiac denervation to prevent postoperative atrial fibrillation after coronary artery bypass grafting

2024-11-17
About The Study: This randomized clinical trial found that partial cardiac denervation was an effective procedure to reduce the occurrence of postoperative atrial fibrillation (POAF) after isolated coronary artery bypass grafting (CABG) without additional postoperative complications. These results suggest that partial cardiac denervation may be a good option for cardiac surgeons to consider for preventing POAF after CABG. Corresponding Authors: To contact the corresponding authors, email Wei Feng, MD, PhD (fengwei@fuwai.com) and Wei Zhao, MD, PhD (zhaowei_fw@163.com). To access the embargoed study: Visit our For The Media website at ...

Finerenone in women and men with heart failure with mildly reduced or preserved ejection fraction

2024-11-17
About The Study: In the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients with Heart Failure (FINEARTS-HF), finerenone reduced the risk of the primary end point similarly in women and men with heart failure with mildly reduced or preserved ejection fraction. Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, had similar tolerability in women and men. Corresponding Author: To contact the corresponding author, John J. V. McMurray, MD, email john.mcmurray@glasgow.ac.uk. To ...

LAST 30 PRESS RELEASES:

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

US tobacco 21 policies and potential mortality reductions by state

AI-driven approach reveals hidden hazards of chemical mixtures in rivers

Older age linked to increased complications after breast reconstruction

ESA and NASA satellites deliver first joint picture of Greenland Ice Sheet melting

Early detection model for pancreatic necrosis improves patient outcomes

[Press-News.org] Scientists lead study on ‘spray on, wash off’ bandages for painful EB condition
Research into new bandaging aims to ease the agony experienced by those living with 'butterfly skin'